Amrita Hospital, Kochi

Amrita Hospital, Kochi EMBRACE GOOD HEALTH
(583)

30/01/2026

ലോക കുഷ്ഠരോഗ ദിനത്തിൽ കുഷ്ഠരോ​ഗത്തിന്റെ പ്രധാനപ്പെട്ട ലക്ഷണങ്ങളെ കുറിച്ചും പ്രതിരോ​ധ മാർ​ഗങ്ങളെ കുറിച്ചും കൊച്ചി അമൃത ഹോസ്പിറ്റലിലെ ക്ലിനിക്കൽ പ്രൊഫസറും ഡെർമറ്റോളജി വിഭാ​ഗം കൺസൾട്ടൻ്റുമായ ഡോ. സൗമ്യ ജഗദീശൻ സംസാരിക്കുന്നു...

A team of doctors and researchers from Amrita Hospital, Kochi and Amrita Vishwa Vidyapeetham has developed an artificial...
28/01/2026

A team of doctors and researchers from Amrita Hospital, Kochi and Amrita Vishwa Vidyapeetham has developed an artificial intelligence system that analyses retinal images to predict the risk of heart attacks, strokes, and kidney diseases, often before any symptoms appear. Since the retina is the only place in the body where blood vessels and nerves can be seen directly without surgery, the technology uses this advantage to identify early warning signs of systemic illness.

The research was led by Dr. Gopal S. Pillai, Head of the Department of Ophthalmology, Amrita Hospital, Kochi, along with a multidisciplinary team including Dr. Rajesh T. Head, Department of Adult Cardiology, Dr. Vivek Nambiar, Head Stroke Medicine, Dr. Merin Dickson, Chief Research Officer Clinical trial Unit,Dr. Nagesh Subbanna, Aishwarya A., Rahul Binu Jacob and Anjana MJ -Research optometrists. Together, the team developed an indigenous AI platform that combines retinal photographs with clinical data to enable fast, non-invasive, and cost-effective screening for large populations.

The technology is already being used in peripheral camps to help doctors identify high-risk patients early and initiate timely treatment, with the potential to significantly reduce complications and healthcare costs through preventive care.

In recognition of its strong ethical foundation, clinical relevance, and real-world impact, the research team has been honoured with the Elsevier RAISE Award, which celebrates excellence in responsible healthcare research and innovation.

27/01/2026

Laughter, fun, magic through the paediatric wards at Amrita Hospital, Kochi as hospital clowns bring joy, comfort, and gentle healing to young hearts.

Because sometimes, the best medicine sounds like laughter.

26/01/2026

A day of pride captured in motion.
Amrita Hospital marked Republic Day with the hoisting of the National Flag by Dr. Gireesh Kumar K P, Principal, Amrita School of Medicine, in the gracious presence of Sampoojya Swami Poornamritanandapuri.

As India celebrates its Republic, we reaffirm our commitment to healing, hope, and inclusive healthcare for all—without ...
25/01/2026

As India celebrates its Republic, we reaffirm our commitment to healing, hope, and inclusive healthcare for all—without distinction.
Wishing everyone a proud Republic Day.

As part of Republic Day observance, Dr. Jayakumar, Professor and Head of Paediatrics at Amrita Hospital, along with our ...
25/01/2026

As part of Republic Day observance, Dr. Jayakumar, Professor and Head of Paediatrics at Amrita Hospital, along with our dedicated staff, stepped beyond hospital walls to serve the community by taking part in a cleanliness drive at the railway station and surrounding areas.

A small step towards a cleaner nation and a healthier future 🇮🇳✨

20/01/2026

പുരികങ്ങൾ മുഖത്തിൻ്റെ സൗന്ദര്യം വർദ്ധിപ്പിക്കുന്നതിൽ നിർണായക പങ്ക് വഹികുന്നുണ്ട്. ഹ്രസ്വകാല ഫലം നൽകുന്ന ബോട്ടക്സ് ഇഞ്ചക്ഷൻ, പ്ലാസ്റ്റിക് സർജറി എന്നിവ പുരികങ്ങളെ മനോഹരമാക്കാൻ സഹായിക്കും. പുരികങ്ങളെ പ്ലാസ്റ്റിക് സർജറി വഴി സൗന്ദര്യവൽക്കരിക്കുന്നത് സംബന്ധിച്ച് പ്ലാസ്റ്റിക് സർജറി വിഭാഗം മേധാവി ഡോ. സന്ദീപ് വിജയരാഘവൻ വിശദീകരിക്കുന്നു.

17/01/2026

പ്ലാസ്റ്റിക് സർജറി വഴി കൺതടങ്ങളെ സുന്ദരമാക്കാൻ സാധിക്കും. കൺതടങ്ങളിലെ തടിപ്പ് അഭംഗിയായി തോന്നുന്നുണ്ടോ? വളരെ ലഘുവായ പ്രക്രിയകളിലൂടെ ഈ പ്രശ്നത്തിന് എങ്ങനെ പരിഹാരം കാണാമെന്ന് പ്ലാസ്റ്റിക് സർജറി വിഭാഗം മേധാവി ഡോ. സന്ദീപ് വിജയരാഘവൻ വിശദീകരിക്കുന്നു.

The scientific arc of Day 3 rose sharply into the frontiers of care—relapsed myeloma in the era of immunotherapy. From s...
12/01/2026

The scientific arc of Day 3 rose sharply into the frontiers of care—relapsed myeloma in the era of immunotherapy. From sBCMA as a biomarker to CAR-T therapies, bispecific antibodies, and early Indian data from the SEHAT study, the sessions reflected a field in rapid motion—hopeful, complex, and demanding equal measures of science and systems.

Panels on CAR-T and BiTE therapies addressed not just efficacy, but feasibility—navigating infections, CRS/ICANS, infrastructure, and access within the Indian and South Asian context. In parallel, a patient group meeting unfolded—quiet yet powerful—bringing lived experience into the heart of the congress. The Closing Remarks and Valedictory marked more than an end—it was a collective pause, a gratitude-filled moment, and a promise to carry forward the conversations begun here.

Over three days, the Myeloma Congress evolved into a living continuum— from precursor states to relapse, from diagnostics to immunotherapy, from data to dignity. Rooted in collaboration and aligned with the global vision championed by the International Myeloma Society, the congress reaffirmed that cures are not discovered in isolation—but shaped through dialogue, access, and shared resolve.

Day 2 began with the spotlight on high-risk myeloma—unpacking Indian realities of risk stratification, evolving genetic ...
12/01/2026

Day 2 began with the spotlight on high-risk myeloma—unpacking Indian realities of risk stratification, evolving genetic and functional definitions, and the integration of cytogenetics, NGS, and MRD in 2026. A powerful panel explored whether modern immunotherapy and transplant strategies can truly overcome high-risk disease.

Discussions then softened—but deepened—into supportive and multidisciplinary care. From infections and nutrition to frailty and organ-specific complications, the sessions reminded us that treating myeloma is as much about sustaining life as it is about extending it.

As evening approached, attention shifted to amyloidosis and dysproteinemias—cardiac involvement, AL amyloidosis, POEMS, Waldenström’s macroglobulinemia, and Indian data—culminating in a candid panel on diagnostic and management challenges across rare plasma cell disorders.

The day concluded with culture and celebration—a shared pause, a collective breath—reminding everyone that science, too, needs rhythm and reflection.

Day 1 of Indian Myeloma Congress 2026 unfolded as a thoughtful arc—from the earliest whispers of disease to decisive fro...
09/01/2026

Day 1 of Indian Myeloma Congress 2026 unfolded as a thoughtful arc—from the earliest whispers of disease to decisive frontline strategies—anchored in evidence, debate, and shared clinical wisdom.

The day opened with an energetic Quiz Prelims, setting a collaborative, learner-driven tone, before moving into a deep exploration of precursor disease and smoldering myeloma. Faculty examined diagnostic blind spots, Indian MGUS data, and global trial insights—culminating in a compelling debate on whether high-risk smoldering myeloma should be treated in India today. The conversations expanded into the future: functional imaging, biomarkers, and AI tools reshaping early detection, alongside reflections on evolving roles of SPE, sFLC, and MRD in diagnosis and prognosis.

The Inaugural Session marked a moment of collective vision—honouring leaders, collaborators, and global partners, while setting the course toward Vision 2030.

Evening sessions turned the lens to newly diagnosed multiple myeloma (NDMM)—addressing access, real-world constraints, frontline regimens, MRD as a therapeutic goal, and the enduring question of transplant versus non-transplant strategies in the era of quadruplets.

The Myeloma Congress is a dedicated academic forum focused on advancing the understanding and management of multiple myeloma and related plasma cell disorders. Bringing together national and international experts, the congress blends cutting-edge science with real-world clinical practice—through debates, panels, case discussions, and hands-on learning.

Address

Amrita Hospital, Ponekkara P. O
Kochi
682041

Telephone

+914842851234

Website

Alerts

Be the first to know and let us send you an email when Amrita Hospital, Kochi posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Amrita Hospital, Kochi:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

EXCEPTIONAL TECHNOLOGY, COMPASSIONATE CARE. Amrita Hospitals are recognised as one of the premier hospitals in South Asia.

In the twenty short years since its inception, Amrita Institute of Medical Sciences (Amrita Hospital) has grown from a 115 bed specialty hospital to a 1300 bed super-specialty tertiary care health centre with an attached medical college hospital. On the 17th of May 1998, Amrita Hospital was inaugurated by the then Prime Minister of India, Shri Atal Bihari Vajpayee, in the presence of Her Holiness, Sri Mata Amritanandamayi Devi.

In the twenty short years since its inception, Amrita Institute of Medical Sciences (Amrita Hospital) has grown from a 115-bed specialty hospital to a 1300 bed super-specialty tertiary care health center with an attached medical college hospital. On the 17th of May 1998, Amrita Hospital was inaugurated by the then Prime Minister of India, Shri Atal Bihari Vajpayee, in the presence of Her Holiness, Sri Mata Amritanandamayi Devi.ments, 45 other departments, 4500 support staff, and 670 faculty members. The hospital is using fully digital imaging services and is the first institution in South East Asia to do this. by Dr. A. P. J. Abdul Kalam, the former President of India. The most recent additions are the DA VINCI SURGICAL ROBOTIC SYSTEM; ROSA, the latest generation in robotic neurosurgery assistance; the MAKO ROBOTIC-ARM ASSISTED TECHNOLOGY which is transforming the way joint replacement surgeries are being performed; a CyberKnife M6 and Tomotherapy for the most precise radiotherapy available today; the GE Voluson E10 4D ultrasound system for spectacular 2D and 3D/4D images; a Philips 256 slice iCT scanner; a PET-3Tesla MRI scanner which is extremely useful for early detection of cancer; and the Digital Pathology Solution, a virtual microscope which digitizes lab slides which more accurately help clinicians in better, faster, cheaper diagnosis and prediction of diseases. FOLLOW US ON TWITTER:

With extensive facilities comprising 28 modern operating theatres, 275 equipped intensive-care beds, a fully computerized and networked Hospital Information System (HIS), a fully digital radiology department, 17 NABL accredited clinical laboratories and a 24/7 telemedicine service, Amrita Hospital offers a total and comprehensive health solution comparable to the best hospitals in the world. There are 12 superspecialty departments, 45 other departments, 4500 support staff and 670 faculty members. The hospital is using fully digital imaging services and is the first institution in South East Asia to do this. by Dr. A. P. J. Abdul Kalam, the former President of India. The most recent additions are the DA VINCI SURGICAL ROBOTIC SYSTEM; ROSA, the latest generation in robotic neurosurgery assistance; the MAKO ROBOTIC-ARM ASSISTED TECHNOLOGY which is transforming the way joint replacement surgeries are being performed; a CyberKnife M6 and Tomotherapy for the most precise radiotherapy available today; the GE Voluson E10 4D ultrasound system for spectacular 2D and 3D/4D images; a Philips 256 slice iCT scanner; a PET-3Tesla MRI scanner which is extremely useful for early detection of cancer; and the Digital Pathology Solution, a virtual microscope which digitizes lab slides which more accurately help clinicians in better, faster, cheaper diagnosis and prediction of diseases. FOLLOW US ON TWITTER: https://twitter.com/AmritaHospitals